| 摘要: |
| ［摘要］ 美罗华是一种抗CD20单克隆抗体，可特异地与B淋巴细胞表面的CD20抗原结合，可治疗B细胞相关的疾病。目前美罗华的临床应用越来越广泛，取得了良好的临床效果。该文就其临床应用进展作一简单综述。 |
| 关键词: 美罗华 治疗 CD20 |
| DOI：10.3969/j.issn.1674-3806.2012.07.32 |
| 分类号:R 730.5 |
| 基金项目: |
|
| Progress on clinical application of rituximab |
|
HUANG Xiao-chun,TAN Yi
|
|
Department of Hematology,the People′s Hospital of Guilin, Guangxi 541002, China
|
| Abstract: |
| ［Abstract］ Rituximab is a kind of anti CD20 monoclonal antibody which can specifically bind with CD20 antigen on B lymphocyte surface. It can be used for the treatment of B cell associated diseases.At present the clinical application of rituximab is more and more extensive. It achieved good clinical results. This article will briefly reviews its clinical application. |
| Key words: Rituximab Therapy CD20 |
